Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study

Meletios A Dimopoulos; Christos Papadimitriou; Georgios Hamilos; Eleni Efstathiou; Georgios Vlahos; Alexandros Rodolakis; Gerasimos Aravantinos; Haralabos P. Kalofonos; Charalambos Kouroussis; Dimitra Gika; Dimosthenis Skarlos; Aristotle Bamias

doi:10.1016/j.ygyno.2004.08.018

Article1998

Favorable Outcome of Ovarian Germ Cell Malignancies Treated with Cisplatin or Carboplatin-Based Chemotherapy: A Hellenic Cooperative Oncology Group Study

Meletios A Dimopoulos, Maria V. Papadopoulou, Eleni Andreopoulou, Chr. Papadimitriou, Nicholas Pavlidis, Gerasimos Aravantinos, A. Aspropotamitis, Αchilles Anagnostopoulos, George Fountzilas, S. Michalas, D. Pectacides

Preprint2023

Suplementary fig 3 from Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

Vı́ctor Moreno, Purificacı́on Muñoz, Milica Stefanović, Miguel Ángel Pujana, Enric Condom, Manel Esteller, Josep R. Germà, Gabriel Capellà, Lourdes Farré, Albert Morales, Francesc Viñals, Xavier García del Muro, Julián Cerón, Alberto Villanueva, Josep M. Piulats, August Vidal, Francisco J. García-Rodríguez, Clara Muñoz, Marga Nadal, Cátia Moutinho, María Martínez‐Iniesta, Josefina Móra, Albert Figueras, Elisabet Guinó, Laura Padullés, Àlvaro Aytés, David G. Mollevı́, Sara Puertas, Carmen Martínez-Fernández, Wilmar Castillo, Mercè Juliachs

Preprint2023

Suplementary fig 3 from Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

Josep M. Piulats, August Vidal, Francisco J. García-Rodríguez, Clara Muñoz, Marga Nadal, Cátia Moutinho, María Martínez‐Iniesta, Josefina Móra, Albert Figueras, Elisabet Guinó, Laura Padullés, Àlvaro Aytés, David G. Mollevı́, Sara Puertas, Carmen Martínez-Fernández, Wilmar Castillo, Mercè Juliachs, Vı́ctor Moreno, Purificacı́on Muñoz, Milica Stefanović, Miguel Ángel Pujana, ,

Article2016

Loss of MGMT promoter methylation and resistance to cisplatin in non-seminomatous germ cell tumors

Cátia Moutinho, Xavier García del Muro, Elisabet Guinó, August Vidal, Sara Puertas, Clara Mu noz, Josep M. Piulats, Alberto Villanueva, Manel Esteller

Article2018

Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

Josep M. Piulats, August Vidal, Francisco J. García-Rodríguez, Clara Muñoz, Marga Nadal, Cátia Moutinho, María Martínez‐Iniesta, Josefina Móra, Albert Figueras, Elisabet Guinó, Laura Padullés, Àlvaro Aytés, David G. Mollevı́, Sara Puertas, Carmen Martínez-Fernández, Wilmar Castillo, Mercè Juliachs, Vı́ctor Moreno, Purificacı́on Muñoz, Milica Stefanović, Miguel Ángel Pujana, Enric Condom,

Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study

Discussion(0)

Related publications

Favorable Outcome of Ovarian Germ Cell Malignancies Treated with Cisplatin or Carboplatin-Based Chemotherapy: A Hellenic Cooperative Oncology Group Study

Suplementary fig 3 from Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

Suplementary fig 3 from Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

Loss of MGMT promoter methylation and resistance to cisplatin in non-seminomatous germ cell tumors

Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent